DSIP vs Semax
A comprehensive, data-driven comparison of DSIP (Delta Sleep-Inducing Peptide) and Semax. Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | DSIP Delta Sleep-Inducing Peptide | Semax |
|---|---|---|
| FDA Status | Category 2 | Not submitted |
| Category | Sleep | Cognitive Enhancement |
| Primary Use | Sleep disorders and stress reduction | Cognitive enhancement and neuroprotection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $45 - $90/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 100-300mcg before bed | 2-3 drops per nostril 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Moderate |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1DSIP is generally more affordable ($35 - $70/mo) compared to Semax ($45 - $90/mo).
- 2DSIP is administered via subcutaneous injection, while Semax uses nasal spray.
- 3Semax has moderate-quality evidence, while DSIP has emerging-quality evidence.
- 4They belong to different categories: DSIP (Sleep) vs Semax (Cognitive Enhancement).
Which Is Better For...
DSIP
More budget-friendly option with lower monthly costs
DSIP
Fewer commonly reported side effects
Semax
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| DSIP | $35 - $70/mo | Category 2 | Various research labs |
| Semax | $45 - $90/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
DSIP works via Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms. Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. They differ in FDA approval status, efficacy data, and cost.
DSIP typically costs $35 - $70/mo, while Semax costs $45 - $90/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
DSIP is not FDA-approved (Category 2). Semax is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of DSIP include Injection site reactions, Drowsiness, Vivid dreams. Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first discovered in 1977 in the brains of sleeping rabbits. Research suggests it may have broader effects on stress response, pain modulation, and...
View Full DSIP GuideSemax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between DSIP and Semax should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.